• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因喘息而住院的婴儿嗜酸性粒细胞活性与持续性儿童哮喘风险。

Eosinophil activity in infants hospitalized for wheezing and risk of persistent childhood asthma.

机构信息

Department of Pediatrics, Kuopio University and Kuopio University Hospital, Kuopio, Finland.

出版信息

Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 1):96-103. doi: 10.1111/j.1399-3038.2009.00873.x. Epub 2009 Sep 30.

DOI:10.1111/j.1399-3038.2009.00873.x
PMID:19793065
Abstract

Eosinophilic inflammation has a central role in the pathogenesis of asthma. We aimed to elucidate whether elevated blood eosinophil count (B-EOS), eosinophil cationic protein in serum (S-ECP) or in nasopharyngeal aspirate (NPA-ECP) predict later asthma after hospitalization for wheezing in infancy. In 1992-1993, 100 infants aged <24 months were hospitalized for wheezing associated with respiratory infection. B-EOS, S-ECP and NPA-ECP were measured on admission. Asthma status was evaluated at the follow-up visits at the median ages of 4.0, 7.2 and 12.3 yr. Twenty (25%) of 81 children had asthma at all three visits and were considered to have persistent childhood asthma (PCA). Children with B-EOS >or= 0.450 x 10(9) cells/l had a 2.9-fold PCA risk compared with other children. The risk was 6.1-fold when S-ECP was >or=20.0 microg/l and 6.7-fold when NPA-ECP was >or=815.0 ng/g. By these cut-off limits, all these markers were specific (75-93%), but not very sensitive (30-58%) in predicting PCA. At least one marker was elevated in 75% of the children with PCA. The respective figure for NPA-ECP alone was 58%. In adjusted analyses, only elevated NPA-ECP was an independent risk factor for PCA (OR 4.09). In conclusion, eosinophil activity in early life predicts the development of childhood asthma after hospitalization for wheezing in infancy. The results highlight NPA-ECP as an independent predictor of the persistence of asthma at school age.

摘要

嗜酸粒细胞炎症在哮喘发病机制中起核心作用。我们旨在阐明婴儿期因喘息住院后,升高的血嗜酸粒细胞计数(B-EOS)、血清(S-ECP)或鼻咽抽吸物(NPA-ECP)中的嗜酸粒细胞阳离子蛋白是否可预测之后的哮喘。1992-1993 年,我们收治了 100 名年龄<24 个月的因呼吸道感染相关喘息住院的婴儿。在入院时检测 B-EOS、S-ECP 和 NPA-ECP。在中位年龄为 4.0、7.2 和 12.3 岁时进行随访以评估哮喘状况。81 名儿童中有 20 名(25%)在所有 3 次就诊时均患有哮喘,被认为患有持续性儿童哮喘(PCA)。B-EOS>或=0.450 x 10(9)个细胞/l 的儿童患 PCA 的风险是其他儿童的 2.9 倍。S-ECP>或=20.0 microg/l 时风险增加至 6.1 倍,NPA-ECP>或=815.0 ng/g 时风险增加至 6.7 倍。通过这些截断值,所有这些标志物在预测 PCA 方面均具有特异性(75-93%),但灵敏度不高(30-58%)。PCA 患儿中至少有 1 种标志物升高的占 75%,而 NPA-ECP 单独升高的比例为 58%。在调整分析中,只有升高的 NPA-ECP 是 PCA 的独立危险因素(OR 4.09)。总之,婴儿期嗜酸粒细胞活性可预测因喘息住院后儿童哮喘的发生。结果突出了 NPA-ECP 作为预测学龄期哮喘持续存在的独立预测因子。

相似文献

1
Eosinophil activity in infants hospitalized for wheezing and risk of persistent childhood asthma.因喘息而住院的婴儿嗜酸性粒细胞活性与持续性儿童哮喘风险。
Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 1):96-103. doi: 10.1111/j.1399-3038.2009.00873.x. Epub 2009 Sep 30.
2
Urine leukotriene E and eosinophil cationic protein in nasopharyngeal aspiration from young wheezy children.幼龄喘息儿童鼻咽抽吸物中的尿白三烯E和嗜酸性粒细胞阳离子蛋白
Pediatr Allergy Immunol. 2005 Aug;16(5):416-21. doi: 10.1111/j.1399-3038.2005.00294.x.
3
[Measurement of serum eosinophil cationic protein levels in wheezing infants].[喘息婴儿血清嗜酸性粒细胞阳离子蛋白水平的测定]
Arerugi. 2002 Dec;51(12):1147-52.
4
Increased eosinophilic cationic protein in nasal fluid in hospitalized wheezy infants with RSV infection.鼻分泌物中嗜酸性阳离子蛋白增加与住院喘息婴儿 RSV 感染相关。
Allergol Int. 2011 Dec;60(4):467-72. doi: 10.2332/allergolint.10-OA-0263. Epub 2011 Jun 25.
5
High levels of eosinophil cationic protein in wheezing infants predict the development of asthma.喘息婴儿中嗜酸性粒细胞阳离子蛋白水平高预示着哮喘的发展。
J Allergy Clin Immunol. 1997 Jun;99(6 Pt 1):752-6. doi: 10.1016/s0091-6749(97)80007-3.
6
Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.儿童哮喘中的嗜酸性粒细胞衍生神经毒素:与疾病严重程度的相关性。
J Asthma. 2010 Jun;47(5):568-73. doi: 10.3109/02770901003792833.
7
[Serum eosinophil cationic protein in infants during first wheezing episode].[首次喘息发作时婴儿血清嗜酸性粒细胞阳离子蛋白]
Arerugi. 1996 Nov;45(11):1161-5.
8
The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.孟鲁司特治疗对哮喘儿童血清白细胞介素-10水平、嗜酸性粒细胞阳离子蛋白、血液嗜酸性粒细胞计数及临床参数的影响。
Turk J Pediatr. 2009 Sep-Oct;51(5):460-5.
9
Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood.儿童早期哮喘、特应性和支气管反应性与血清嗜酸性粒细胞阳离子蛋白的关系。
J Allergy Clin Immunol. 2004 Nov;114(5):1040-5. doi: 10.1016/j.jaci.2004.07.051.
10
Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing.不同细胞因子谱和嗜酸性粒细胞活化参与鼻病毒和呼吸道合胞病毒引起的儿童喘息急性加重。
Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 2):e87-94. doi: 10.1111/j.1399-3038.2010.01026.x.

引用本文的文献

1
Early Prediction of Asthma.哮喘的早期预测
J Clin Med. 2023 Aug 20;12(16):5404. doi: 10.3390/jcm12165404.
2
Increased fecal human beta-defensin-2 expression in preterm infants is associated with allergic disease development in early childhood.早产婴儿粪便中人类β-防御素-2表达增加与儿童早期过敏性疾病的发展有关。
World Allergy Organ J. 2022 May 11;15(5):100633. doi: 10.1016/j.waojou.2022.100633. eCollection 2022 May.
3
Factors predicting persistence of early wheezing through childhood and adolescence: a systematic review of the literature.
预测儿童期及青少年期早期喘息持续存在的因素:文献系统综述
J Asthma Allergy. 2017 Mar 27;10:83-98. doi: 10.2147/JAA.S128319. eCollection 2017.
4
Current and future management of the young child with early onset wheezing.婴幼儿早发性喘息的当前及未来管理
Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):146-152. doi: 10.1097/ACI.0000000000000341.
5
Clinical and Virus Surveillance After the First Wheezing Episode: Special Reference to Rhinovirus A and C Species.首次喘息发作后的临床及病毒监测:特别提及A种和C种鼻病毒
Pediatr Infect Dis J. 2017 Jun;36(6):539-544. doi: 10.1097/INF.0000000000001495.